PD Neurotechnology
PrivateLast Round
Series A
Apr 25, 2023
Est. Valuation
$38.1M
Total Funding Raised
$9.39M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PD Neurotechnology operates in Healthcare & Life Sciences and is based in Athens. Its latest recorded funding round was a Series A round in April 2023.
PD Neurotechnology is a medical technology company that develops wearable medical devices and digital health solutions for the continuous monitoring and treatment of Parkinson's disease and other movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PD Neurotechnology Comparables
Compare PD Neurotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sense4Care | 87% | |
| Great Lakes NeuroTechnologies Inc. | 84% | |
| SERG Technologies | 83% |
For institutional investors. Book with your work email.
PD Neurotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2023 | ||||
| Seed | Nov 15, 2019 |
For institutional investors. Book with your work email.
PD Neurotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Onassis Foundation | Series A, Seed |
| National Bank of Greece | Series A |
| SeedBlink | Series A |
| Crimson International Investment | Series A |
| Big Pi Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 65% MoM.
- Jun 1, 2025
Monthly visitors grew 43% MoM, from 700 to 1K.
For institutional investors. Book with your work email.
PD Neurotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PD Neurotechnology's valuation, stock price, and market status.
Is PD Neurotechnology a public or private company?
PD Neurotechnology is a private company.
What is the current stock price of PD Neurotechnology?
PD Neurotechnology is a private company, so its shares have no public market price. Caplight tracks PD Neurotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PD Neurotechnology worth (valuation)?
PD Neurotechnology's valuation is estimated at $38.1M based on funding round data.
Can I buy PD Neurotechnology stock?
PD Neurotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PD Neurotechnology's last funding round?
PD Neurotechnology's most recent funding round was Series A on April 25, 2023.
Who are the main investors in PD Neurotechnology?
Key investors in PD Neurotechnology include Onassis Foundation, Crimson International Investment, Big Pi Ventures.
Will PD Neurotechnology IPO soon?
No public IPO plans have been announced for PD Neurotechnology.
How can I track PD Neurotechnology secondary market activity?
Caplight tracks bids, offers, and trades in PD Neurotechnology's shares on secondary markets.